Predict your next investment

Corporation
HEALTHCARE | Biotechnology
10xgenomics.com

See what CB Insights has to offer

Founded Year

2012

Stage

IPO | IPO

Total Raised

$277.04M

Date of IPO

9/12/2019

Market Cap

19.76B

Stock Price

155.67

About 10X Genomics

10X Genomics is a life science technology company building products to interrogate, understand and master biology. Its integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology.

10X Genomics Headquarter Location

6230 Stoneridge Mall Road

Pleasanton, California, 94588,

United States

925-401-7300

Latest 10X Genomics News

Genomics Market Witnesses Emergence of 10X Genomics Inc. & Abcam Plc as Key Market Contributors|17000+ Technavio Reports

Sep 14, 2021

|17000+ Technavio Reports News provided by Share this article Share this article NEW YORK, Sept. 14, 2021 /PRNewswire/ -- The genomics market is set to grow by $ 14.51 bn, progressing at a CAGR of over 10.36% during 2021-2025. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. Technavio has announced its latest market research report titled Genomics Market by Solution and Geography - Forecast and Analysis 2021-2025 The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. 10X Genomics Inc., Abcam Plc, Agilent Technologies Inc., Becton Dickinson and Co., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Danaher Corp., Eppendorf AG, Eurofins Scientific SE, and F. Hoffmann-La Roche Ltd. are some of the major market participants. The rising investments in genomic research & development and increasing demand for creating and upgrading genome databases will offer immense growth opportunities for the market vendors. Genomics Market 2021-2025: Segmentation Genomics Market 2021-2025: Vendor Analysis and Scope To help businesses improve their market position, Technavio's report provides a detailed analysis of around 25 vendors operating in the market. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments. The report also covers the following areas: Genomics Market size Genomics Market industry analysis Market trend such as reduction in the cost of genetic sequencing is likely to emerge as one of the primary drivers of the market. However, factors such as varying regulations in genomic research and testing may threaten the growth of the market. Register for a free trial today and gain instant access to 17,000+ market research reports. Related Reports on Health Care Include: Hepatitis B and C Diagnostics Market Report - The hepatitis B and C diagnostics market have the potential to grow by USD 1.72 billion during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 6.22%. Download a free sample report now! Gel Permeation Chromatography Market Report -The gel permeation chromatography market has the potential to grow by USD 455.30 million during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 6.38%. Download a free sample report now! Genomics Market 2021-2025: Key Highlights CAGR of the market during the forecast period 2021-2025 Detailed information on factors that will assist genomics market growth during the next five years Estimation of the genomics market size and its contribution to the parent market Predictions on upcoming trends and changes in consumer behavior The growth of the genomics market Analysis of the market's competitive landscape and detailed information on vendors Comprehensive details of factors that will challenge the growth of genomics market vendors Table of Contents: Research methodology List of abbreviations Technavio's in-depth market research reports now include a thorough analysis of the COVID-19 impact on various markets to help industry leaders navigate their business through the new normal. About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing 10X Genomics

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned 10X Genomics in 4 CB Insights research briefs, most recently on Aug 26, 2021.

Expert Collections containing 10X Genomics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

10X Genomics is included in 6 Expert Collections, including Genomics.

G

Genomics

823 items

Companies involved in the capture, sequencing, and/or analysis of genetic data

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

S

SoftBank Investments 2017-2019

146 items

D

Deloitte 2019 Technology Fast500 - North America

501 items

B

Biopharmaceuticals

5,732 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

O

Omics

1,025 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

10X Genomics Patents

10X Genomics has filed 268 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Biotechnology
  • DNA
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/5/2018

8/10/2021

Fluid dynamics, Biotechnology, Microfluidics, Molecular biology, AMC (TV channel) network shows

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/5/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/10/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Fluid dynamics, Biotechnology, Microfluidics, Molecular biology, AMC (TV channel) network shows

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

10X Genomics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

10X Genomics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.